CYP2D6 POLYMORPHISMS AND ADVERSE EVENTS TO RISPERIDONE IN CHILDREN AND ADOLESCENTS.

被引:0
|
作者
Neely, K. M. [1 ]
Oshikoya, K. A. [1 ]
Carroll, R. [1 ]
Aka, I. [1 ]
Maxwell-Horn, A. [1 ]
Roden, D. M. [1 ]
Van Driest, S. L. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PGRN-027
引用
收藏
页码:S22 / S23
页数:2
相关论文
共 50 条
  • [31] Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo
    Storset, Elisabet
    Braten, Line Skute
    Ingelman-Sundberg, Magnus
    Johansson, Inger
    Molden, Espen
    Kringen, Marianne Kristiansen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (10) : 1531 - 1541
  • [32] The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation
    de Leon, J
    Susce, MT
    Pan, RM
    Fairchild, M
    Koch, WH
    Wedlund, PJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) : 15 - 27
  • [33] CYP2D6 polymorphisms associated with tamoxifen outcome
    Hutchinson L.
    Nature Reviews Clinical Oncology, 2009, 6 (12) : 675 - 675
  • [35] Functional characterization of CYP2D6 enhancer polymorphisms
    Wang, Danxin
    Papp, Audrey C.
    Sun, Xiaochun
    HUMAN MOLECULAR GENETICS, 2015, 24 (06) : 1556 - 1562
  • [36] Polymorphisms of CYP2D6 in the Czech population.
    Slanar, Ondrej
    Buzkova, Helena
    Pechandova, Kristina
    Matouskova, Olga
    Perlik, Frantisek
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 232 - 232
  • [37] CYP2D6 Polymorphisms and the impact on tamoxifen therapy
    Beverage, Jacob N.
    Sissung, Tristan M.
    Sion, Amy M.
    Danesi, Romano
    Figg, William D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (09) : 2224 - 2231
  • [38] Molecular dynamics analysis of CYP2D6 polymorphisms
    DeWaal, Parker
    Furge, Laura
    FASEB JOURNAL, 2014, 28 (01):
  • [39] Genetic polymorphisms of CYP2D6 in Chinese mainland
    Ji, L
    Pan, SX
    Wu, JM
    Marti-Jaun, J
    Hersberger, M
    CHINESE MEDICAL JOURNAL, 2002, 115 (12) : 1780 - 1784
  • [40] Impact of ABCB1 and CYP2D6 polymorphisms on tamoxifen treatment outcomes and adverse events in breast cancer patients
    Argalacsova, Sona
    Slanar, Ondrej
    Bakhouche, Hana
    Pertuzelka, Lubos
    JOURNAL OF BUON, 2017, 22 (05): : 1217 - 1226